<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="70416">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01790841</url>
  </required_header>
  <id_info>
    <org_study_id>54</org_study_id>
    <nct_id>NCT01790841</nct_id>
  </id_info>
  <brief_title>DF4 Master Study (Safety and Efficacy Study)</brief_title>
  <official_title>Master Study of the BIOTRONIK DF4 System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <authority>Austria: AGES (Bundesamt f√ºr Sicherheit im Gesundheitswesen)</authority>
    <authority>Italy: Ministry of Labour, Health and Social Affairs</authority>
    <authority>France: French medicines and healthcare products safety agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to proof the safety and efficacy of the new ICD sytem
      (Iforia/Ilesto). The devices are available with DF-1 and DF4 connection. A special focus is
      set on the ICD system with DF4 connection.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Serious adverse device effect (SADE) rate related to the ICD with DF4 connection</measure>
    <time_frame>until 3 month follow-up</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>SADE rate related to the Linox smart DF4 lead (ICD shock lead)</measure>
    <time_frame>until 3 month follow-up</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Shift rate of the painless shock impedance measurement</measure>
    <time_frame>between 3 and 6 month follow-up</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Pacing threshold comparison between Linox smart DF-1 and Linox smart DF4 lead</measure>
    <time_frame>3 month follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of automatic atrial pacing threshold test vs. manual measurement</measure>
    <time_frame>3 month follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">237</enrollment>
  <condition>Ventricular Tachycardia</condition>
  <condition>Ventricular Fibrillation</condition>
  <condition>Sudden Cardiac Death</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>ICD system with DF4 connection</arm_group_label>
    <description>Iforia/Ilesto ICD with DF4 connection and Linox smart DF4 lead/ Protego</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICD system with DF-1 connection</arm_group_label>
    <description>Ilesto/Iforia ICD with DF-1 connection</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Iforia/Ilesto ICD/CRT-D, Linox smart DF4 lead/ Protego</intervention_name>
    <arm_group_label>ICD system with DF4 connection</arm_group_label>
    <arm_group_label>ICD system with DF-1 connection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with standard ICD/CRT-D indication who are referred to the hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient has provided written informed consent.

          -  Patient has standard ICD/CRT-D indication.

          -  Patient accepts Home Monitoring concept.

          -  Patient is able to attend the planned hospital follow-up visits.

          -  Patient has legal capacity and ability to consent.

        Exclusion Criteria:

          -  Patient has a standard contra-indication for ICD/CRT-D therapy.

          -  Age &lt; 18 years

          -  Patient is pregnant or breastfeeding.

          -  Patient is expected to receive ventricular assist device or heart transplantation
             within the next 12 months.

          -  Life expectancy of less than 12 months.

          -  Participating in any other clinical study of an investigational cardiac drug or
             device.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universitaetsmedizin Greifswald</name>
      <address>
        <city>Greifswald</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 11, 2014</lastchanged_date>
  <firstreceived_date>February 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Death</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
